Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The phase 1/2 trial of indomethacin in chronic pancreatitis (The PAIR trial): Protocol for a parallel multi-center randomized controlled trial

Pancreatology(2022)10.1016/j.pan.2022.12.008Source: DataRank Database

The phase 1/2 trial of indomethacin in chronic pancreatitis (The PAIR trial): Protocol for a parallel multi-center randomized controlled trial is a research paper published in Pancreatology (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.89)OA: greenTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Darwin L. Conwell ORCID,Liang Li ORCID,Alejandra Cervantes,Phil A. Hart,Zobeida Cruz‐Monserrate ORCID

Live enrichment

PubMed:36535851 PMC:PMC9839482 OpenAlex:https://openalex.org/W4311459810

NIDDK NIH HHS

Grant: U01 DK108288

NIDDK NIH HHS

Grant: U01 DK108327

NIDDK NIH HHS

Grant: R21 DK117212

National Institutes of Health

FWCI

1.89

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9839482

publisherhttps://api.elsevier.com/content/article/PII:S1424390322008304?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1424390322008304?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.pan.2022.12.008

Fields of Study

Pancreatitis Pathology and TreatmentPancreatic and Hepatic Oncology ResearchGallbladder and Bile Duct Disorders

MeSH Terms

Anti-Inflammatory Agents, Non-SteroidalHumansIndomethacinPancreasQuality of LifeMulticenter Studies as TopicRandomized Controlled Trials as TopicClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicPancreatitis, Chronic

Keywords

MedicinePancreatitisPlaceboRandomized controlled trialProstaglandin E2SalivaGastroenterologyInternal medicinePathology

Sustainable Development Goals

SDG 0: Good health and well-being

The phase 1/2 trial of indomethacin in chronic pancreatitis (The PAIR trial): Protocol for a parallel multi-center randomized controlled trial

FAIR Checklist

Authors (14)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)